Home » FAQs » Avexa Demerger » What was the nominal cost of the shares of Avexa Limited when it was spun off from Amrad Corporation » Avexa Demerger

Avexa Demerger

Avexa
  • Home
  • News
    • Press Releases 2010
    • Press Releases 2009
    • Press Releases 2008
    • Press Releases 2007
    • Press Releases 2006
    • Press Releases 2005
  • Corporate
    • Company Overview
    • Business Development
    • People
    • Corporate Governance
    • Avexa Employee Share Option Plan
  • Investor Relations
    • AGM
    • Company Reports
    • Prospectus 2007
    • Shareholder Newsletters
    • Analyst Reports
    • Investor Centre
  • Presentations
    • CEO's presentation to the 2009 AGM
    • Chairman's address to the 2009 AGM
    • Company Presentation April 2009
    • HIV Glasgow Conference November 2008 Apricitabine Oral Presentation
    • HIV Glasgow Conference November 2008 Apricitabine Poster
    • ICAAC Poster Washington 2008
    • AGM CEO Presentation November 2008
    • Poster XV11 HIV Drug Resistance Workshop June 2008
    • Investor Presentation March 2008
    • BIO CEO Investor Conference New York February 2008
    • CROI Poster Boston 2008
    • CEO Presentation AGM 2007
    • Investor Presentation October 2007
    • Investor Roadshow Presentation 2007
    • Investor Roadshow Presentation March 2007
    • HIV Glasgow Conference November 2006 Apricitabine Poster
    • AGM CEO presentation 2006
    • Investor Roadshow Presentation November 2006
  • FAQs
    • Avexa Demerger
    • General
    • Annual Report Information
    • Shareholder Information
  • Contact Us
    • Contact Form
    • Careers
Search     Site Map
Terms and Conditions |  Privacy Statement |  © 2008 Avexa Limited All Rights Reserved